| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Guardant Health, Inc. | Director | Common Stock | 18.3K | $1.23M | $66.95 | Oct 17, 2025 | Direct |
| Ginkgo Bioworks Holdings, Inc. | Director | Restricted Stock Units | 0 | $238K | $0.55 | Jun 11, 2025 | Direct |
| Ginkgo Bioworks Holdings, Inc. | Director | Class A Common Stock | 10.8K | $87.9K | $8.12 | Jun 11, 2025 | Direct |
| Guardant Health, Inc. | Director | Restricted Stock Units | 0 | $17.5K | $42.47 | Oct 15, 2025 | Direct |
| Ginkgo Bioworks Holdings, Inc. | Director | Stock Option | 571K | Jun 13, 2024 | Direct | ||
| Guardant Health, Inc. | Director | Stock Option (Right to Buy) | 6.83K | Jun 18, 2025 | Direct | ||
| Myovant Sciences Ltd. | Director | Common Shares | 0 | $27.00 | Mar 10, 2023 | Direct | |
| Myovant Sciences Ltd. | Director | Stock Options (Right to Buy) | 0 | Mar 10, 2023 | Direct |